ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer.

dataset, we also found that CG-1 and CG-2 tumors were more likely to experience biochemical relapse over a 5-year period relative to A-Low tumors, although at modest significance ( Supplementary Figure S3 ).

also in 149 other papers